Prevalence and Comorbidity of Atopic Dermatitis in Children: A Large-Scale Population Study Based on Real-World Data.
Spain
atopic dermatitis
children
comorbidity
multimorbidity
prevalence
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
28 May 2020
28 May 2020
Historique:
received:
28
04
2020
revised:
20
05
2020
accepted:
25
05
2020
entrez:
3
6
2020
pubmed:
3
6
2020
medline:
3
6
2020
Statut:
epublish
Résumé
This study aimed at exploring atopic dermatitis (AD) prevalence in children and exhaustively analyzing their comorbidity. We conducted a descriptive analysis of their socio-demographic and comorbidity characteristics in the EpiChron Cohort (Aragón, Spain). Adjusted odds ratios (OR) were calculated for each comorbidity using logistic regression models. In total, 33,591 children had a diagnosis of AD, resulting in an overall prevalence of 15.5%. AD prevalence was higher in girls compared to boys, in 3-9-year-olds compared to children of other ages, and in Spanish children compared to those of other nationalities. Multimorbidity was present in 43% of children, with the most frequent chronic comorbidities being asthma (13.1%), psychosocial disorders (7.9%), and visual impairment (7.8%). Many diseases were, regardless of their prevalence, statistically associated with AD. The strongest associations (odds ratio (OR) (95% confidence interval (CI))) were found in asthma (2.10 (2.02-2.17)), allergic rhinitis (2.00 (1.91-2.10)), and irritable bowel syndrome (1.90 (1.56-2.31)). A better understanding of the array of comorbidities associated with AD in children might help improve their clinical management. Future longitudinal studies are encouraged to shed light on the potential underlying pathophysiological mechanisms involved in the identified associations.
Identifiants
pubmed: 32481591
pii: jcm9061632
doi: 10.3390/jcm9061632
pmc: PMC7356227
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Gobierno de Aragón and European Regional Development Fund
ID : B01_20R and B18_17D
Références
J Investig Allergol Clin Immunol. 2009;19 Suppl 2:27-33
pubmed: 19530415
J Eur Acad Dermatol Venereol. 2019 Sep;33(9):1762-1767
pubmed: 31045273
Arch Dis Child. 2011 Nov;96(11):1042-6
pubmed: 21903597
J Am Acad Dermatol. 2014 Mar;70(3):569-75
pubmed: 24342754
Int J Epidemiol. 2018 Apr 1;47(2):382-384f
pubmed: 29346556
Australas J Dermatol. 2020 Feb;61(1):e60-e64
pubmed: 31506928
J Allergy Clin Immunol. 2010 Feb;125(2):404-10
pubmed: 20159252
J Am Acad Dermatol. 2019 Feb;80(2):382-389
pubmed: 30287311
Ann Allergy Asthma Immunol. 2018 Nov;121(5):604-612.e3
pubmed: 30092266
Pediatrics. 2007 Jan;119(1):86-93
pubmed: 17200274
Pediatr Dermatol. 2018 Mar;35(2):164-169
pubmed: 29334143
Br J Dermatol. 2008 Mar;158(3):539-43
pubmed: 18067476
J Allergy Clin Immunol. 2009 Dec;124(6):1251-8.e23
pubmed: 20004783
Nat Genet. 2015 Dec;47(12):1449-1456
pubmed: 26482879
Clin Dermatol. 2017 Jul - Aug;35(4):360-366
pubmed: 28709566
Chronobiol Int. 2008 Jul;25(4):549-64
pubmed: 18622815
Br J Gen Pract. 2011 Jan;61(582):e12-21
pubmed: 21401985
Dermatology. 2015;231(1):35-40
pubmed: 25966818
Pediatr Allergy Immunol. 2013 Aug;24(5):476-86
pubmed: 23773154
Ann Allergy Asthma Immunol. 2014 Jun;112(6):525-32
pubmed: 24713577
Actas Dermosifiliogr. 2013 Jan;104(1):44-52
pubmed: 22841507
J Am Acad Dermatol. 2018 Sep;79(3):448-456.e30
pubmed: 30119868
Rev Esp Salud Publica. 2018 Dec 10;92:
pubmed: 30531710
J Clin Sleep Med. 2010 Dec 15;6(6):581-8
pubmed: 21206547
Int J Clin Pract. 2006 Aug;60(8):984-92
pubmed: 16893440
J Investig Med. 2018 Apr;66(4):755-761
pubmed: 29374025
Int J Biometeorol. 2008 Nov;52(8):833-40
pubmed: 18779981
BMJ Open. 2017 Nov 12;7(11):e018091
pubmed: 29133326
Ann Nutr Metab. 2015;66 Suppl 1:8-16
pubmed: 25925336
Am J Clin Dermatol. 2018 Dec;19(6):821-838
pubmed: 30168085
Pediatr Allergy Immunol. 2004 Jun;15(3):234-41
pubmed: 15209956
J Eur Acad Dermatol Venereol. 2018 Aug;32(8):1246-1255
pubmed: 29444366
Allergol Immunopathol (Madr). 2016 Mar-Apr;44(2):120-4
pubmed: 26251203
Pharmacoeconomics. 2003;21(2):105-13
pubmed: 12515572
J Allergy Clin Immunol. 2014 Jan;133(1):147-53
pubmed: 23810764
J Allergy Clin Immunol. 2014 Apr;133(4):1041-7
pubmed: 24094542
Dermatol Clin. 2017 Jul;35(3):395-402
pubmed: 28577807
Lancet. 2006 Aug 26;368(9537):733-43
pubmed: 16935684
Arch Pediatr Adolesc Med. 1999 Mar;153(3):249-53
pubmed: 10086401
Allergy. 2020 Jan;75(1):63-74
pubmed: 31194890
J Am Acad Dermatol. 2014 Feb;70(2):338-51
pubmed: 24290431
J Allergy Clin Immunol. 2003 Dec;112(6 Suppl):S118-27
pubmed: 14657842
Indian J Dermatol. 2019 Sep-Oct;64(5):355-359
pubmed: 31543528
J Allergy Clin Immunol. 2013 Feb;131(2):428-33
pubmed: 23245818